Fetal valproate syndrome

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs